申请人:SMITHKLINE BEECHAM CORP
公开号:WO2001026654A1
公开(公告)日:2001-04-19
Compounds of formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections wherein: R1 is C¿1-4?alkyl; R?2¿ is C¿1-4?alkyl; R?3¿ is -C¿1-4?alkyl, -C0-4alkyl-Ar or -C0-4alkyl-Het; R?4¿ is -C¿1-4?alkyl, -(CH2)1-4OH, -OC1-4alkyl, -SC1-4alkyl, -N(C1-4alkyl)2, -C0-4alkyl-Ar, -C0-4alkyl-Het, -C0-4alkyl-C3-6cycloalkyl, -CH(OH)-CH2-R* or -(CH2)1-3SO2Ar; R* is C1-4alkyl, Ar or Het; X is H, C1-4alkyl, OR', SR', CN, N(R')2, CH2N(R')2, NO2, CF3, CO2R', CON(R')2, COR', NR'C(O)R', F, Cl, Br, I, or -S(O)rCF3; R' is H, C1-6alkyl or -C0-6alkyl-Ar; and r is 0, 1 or 2; or a pharmaceutically acceptable salt thereof.